Puttarin Kulchaitanaroaj
Biographic Data
| ID | 5537864 |
|---|---|
| NAME | Puttarin Kulchaitanaroaj |
| GIVEN NAMES | Puttarin |
| FAMILY NAME | Kulchaitanaroaj |
| SIGNATURE | KULCHAITANAROAJ P |
| AFFILIATIONS | Brunel University of London |
| ORCID | 0000-0002-8710-9863 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2015 |
| H-INDEX | 0 |
Statin Use After Acute Myocardial Infarction by Patient Complexity: Are the Rates Right
BACKGROUND: Guidelines suggest statin use after acute myocardial infarction (AMI) should be close to universal in patients without safety concerns yet rates are much lower than recommended, decline with patient complexity, and display substantial geographic variation. Trial exclusions have resulted in little evidence to guide statin prescribing for complex patients. OBJECTIVE: To assess the benefits and risks associated with higher rates of stati…
Geographic Variation in Statin Use for Complex Acute Myocardial Infarction Patients: Evidence of Effective Care
BACKGROUND: Despite strong evidence to designate statin use for secondary prevention of cardiovascular disease (CVD) as "effective care," observational studies show that many patients with CVD do not receive statins. This suggests that statin prescribing decisions for complex CVD patients are preference sensitive. OBJECTIVES: The aim of this study was to evaluate local area variation in statin prescribing for subsets of complex patients after acu…
No prominent works on this page.
Geographic Variation in Statin Use for Complex Acute Myocardial Infarction Patients: Evidence of Effective Care
BACKGROUND: Despite strong evidence to designate statin use for secondary prevention of cardiovascular disease (CVD) as "effective care," observational studies show that many patients with CVD do not receive statins. This suggests that statin prescribing decisions for complex CVD patients are preference sensitive. OBJECTIVES: The aim of this study was to evaluate local area variation in statin prescribing for subsets of complex patients after acu…
Statin Use After Acute Myocardial Infarction by Patient Complexity: Are the Rates Right
BACKGROUND: Guidelines suggest statin use after acute myocardial infarction (AMI) should be close to universal in patients without safety concerns yet rates are much lower than recommended, decline with patient complexity, and display substantial geographic variation. Trial exclusions have resulted in little evidence to guide statin prescribing for complex patients. OBJECTIVE: To assess the benefits and risks associated with higher rates of stati…
Emergency Medicine (2 works) · Emergency Medicine (2 works) · Intensive care medicine (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Lipoproteins and Cardiovascular Health (2 works) · Medicine (2 works) · Myocardial infarction (2 works) · Physical therapy (2 works) · Statin (2 works)